MedTrace Logo

The Effects of Losartan on Emotion Processing

NCT04606212 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-10-28

No results posted yet for this study

Summary

The aim of the study is to investigate the effect of losartan (50mg, single dose) on salience processing

Conditions

  • Healthy

Interventions

DRUG

Losartan

administration of losartan (50 mg) (oral)

DRUG

Placebo Oral Tablet

administration of placebo (oral)

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Benjamin Becker, PhD · University of Electronic Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-10
Primary Completion
2021-12-31
Completion
2022-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04606212 on ClinicalTrials.gov